13-2112: 6HBW , 1A00 , 1A01 , 1A0U , 1A0Z , 1A3N , 1A3O , 1ABW , 1ABY , 1AJ9 , 1B86 , 1BAB , 1BBB , 1BIJ , 1BUW , 1BZ0 , 1BZ1 , 1BZZ , 1C7B , 1C7C , 1C7D , 1CBL , 1CBM , 1CH4 , 1CLS , 1CMY , 1COH , 1DKE , 1DXT , 1DXU , 1DXV , 1FN3 , 1G9V , 1GBU , 1GBV , 1GLI , 1GZX , 1HAB , 1HAC , 1HBA , 1HBB , 1HBS , 1HCO , 1HDB , 1HGA , 1HGB , 1HGC , 1HHO , 1IRD , 1J3Y , 1J3Z , 1J40 , 1J41 , 1J7S , 1J7W , 1J7Y , 1JY7 , 1K0Y , 1K1K , 1KD2 , 1LFL , 1LFQ , 1LFT , 1LFV , 1LFY , 1LFZ , 1LJW , 1M9P , 1MKO , 1NEJ , 1NIH , 1NQP , 1O1I , 1O1J , 1O1K , 1O1L , 1O1M , 1O1N , 1O1O , 1O1P , 1QI8 , 1QSH , 1QSI , 1QXD , 1QXE , 1R1X , 1R1Y , 1RPS , 1RQ3 , 1RQ4 , 1RQA , 1RVW , 1SDK , 1SDL , 1THB , 1UIW , 1VWT , 1XXT , 1XY0 , 1XYE , 1XZ2 , 1XZ4 , 1XZ5 , 1XZ7 , 1XZU , 1XZV , 1Y09 , 1Y0A , 1Y0C , 1Y0D , 1Y0T , 1Y0W , 1Y22 , 1Y2Z , 1Y31 , 1Y35 , 1Y45 , 1Y46 , 1Y4B , 1Y4F , 1Y4G , 1Y4P , 1Y4Q , 1Y4R , 1Y4V , 1Y5F , 1Y5J , 1Y5K , 1Y7C , 1Y7D , 1Y7G , 1Y7Z , 1Y83 , 1Y85 , 1Y8W , 1YDZ , 1YE0 , 1YE1 , 1YE2 , 1YEN , 1YEO , 1YEQ , 1YEU , 1YEV , 1YFF , 1YG5 , 1YGD , 1YGF , 1YH9 , 1YHE , 1YHR , 1YIE , 1YIH , 1YVQ , 1YVT , 1YZI , 2D5Z , 2D60 , 2DN1 , 2DN2 , 2DN3 , 2DXM , 2H35 , 2HBC , 2HBD , 2HBE , 2HBF , 2HBS , 2HCO , 2HHD , 2HHE , 2M6Z , 2W6V , 2W72 , 2YRS , 3B75 , 3D17 , 3D7O , 3DUT , 3HXN , 3IC0 , 3IC2 , 3KMF , 3NL7 , 3NMM , 3ODQ , 3ONZ , 3OO4 , 3OO5 , 3P5Q , 3QJB , 3QJC , 3QJD , 3QJE , 3R5I , 3S65 , 3S66 , 3SZK , 3W4U , 3WCP , 3WHM , 4FC3 , 4HHB , 4IJ2 , 4L7Y , 4M4A , 4M4B , 4MQC , 4MQG , 4MQH , 4MQI , 4N7N , 4N7O , 4N7P , 4N8T , 4NI0 , 4NI1 , 4ROL , 4ROM , 4WJG , 4X0L , 4XS0 , 5E29 , 5E6E , 5EE4 , 5HU6 , 5JDO , 5KDQ , 5E83 3043 101488143 ENSG00000244734 ENSMUSG00000073940 P68871 P02088 NM_000518 NM_008220 NP_000509 NP_032246 NP_001188320 NP_001265090 Hemoglobin subunit beta ( beta globin , β-globin , haemoglobin beta , hemoglobin beta )
26-453: A curiosity, the same mutation was also associated to a decrease in serum LDL levels in carriers, so the authors suggest that is due to the need of cholesterol to regenerate cell membranes. More than a thousand naturally occurring HBB variants have been discovered. The most common is HbS, which causes sickle cell disease . HbS is produced by a point mutation in HBB in which the codon GAG
39-424: Is a globin protein , coded for by the HBB gene, which along with alpha globin ( HBA ), makes up the most common form of haemoglobin in adult humans, hemoglobin A (HbA). It is 147 amino acids long and has a molecular weight of 15,867 Da . Normal adult human HbA is a heterotetramer consisting of two alpha chains and two beta chains. β-globin is encoded by the HBB gene on human chromosome 11 . Mutations in
52-675: Is a severe medical condition. A severe anemia is seen starting at 6 months of age. Without medical treatment death often occurs before age 12. Beta thalassemia major can be treated by lifelong blood transfusions or bone marrow transplantation . According to a recent study, the stop gain mutation Gln40stop in HBB gene is a common cause of autosomal recessive Beta- thalassemia in Sardinian people (almost exclusive in Sardinia). Carriers of this mutation show an enhanced red blood cell count. As
65-647: Is at the same position in HbS, but glutamic acid is replaced by lysine (β6Glu→Lys). The mutation is particularly prevalent in West African populations. HbC provides near full protection against Plasmodium falciparum in homozygous (CC) individuals and intermediate protection in heterozygous (AC) individuals. This indicates that HbC has stronger influence than HbS, and is predicted to replace HbS in malaria-endemic regions. Another point mutation in HBB, in which glutamic acid
78-500: Is made, and β+, in which a small amount of normal β-globin protein is produced. Beta thalassemia minor occurs when an individual inherits one normal Beta allele and one abnormal Beta allele (either β0, or β+). Beta thalassemia minor results in a mild microcytic anemia that is often asymptomatic or may cause fatigue and or pale skin. Beta thalassemia major occurs when a person inherits two abnormal alleles. This can be either two β+ alleles, two β0 alleles, or one of each. Beta thalassemia major
91-420: Is replaced by GTG. This results in the replacement of hydrophilic amino acid glutamic acid with the hydrophobic amino acid valine at the seventh position (β6Glu→Val). This substitution creates a hydrophobic spot on the outside of the protein that sticks to the hydrophobic region of an adjacent hemoglobin molecule's beta chain. This further causes clumping of HbS molecules into rigid fibers, causing "sickling" of
104-473: Is replaced with lysine at position 26 (β26Glu→Lys), leads to the formation of haemoglobin E (HbE). HbE has a very unstable α- and β-globin association. Even though the unstable protein itself has mild effect, inherited with HbS and thalassemia traits, it turns into a life-threatening form of β-thalassemia. The mutation is of relatively recent origin suggesting that it resulted from selective pressure against severe falciparum malaria, as heterozygous allele prevents
117-483: The development of malaria. Malaria due to Plasmodium falciparum is a major selective factor in human evolution . It has influenced mutations in HBB in various degrees resulting in the existence of numerous HBB variants. Some of these mutations are not directly lethal and instead confer resistance to malaria, particularly in Africa where malaria is epidemic. People of African descent have evolved to have higher rates of
130-429: The entire red blood cells in the homozygous ( HbS/HbS ) condition. The homozygous allele has become one of the deadliest genetic factors, whereas people heterozygous for the mutant allele ( HbS/HbA ) are resistant to malaria and develop minimal effects of the anaemia. Sickle cell disease is closely related to another mutant haemoglobin called haemoglobin C (HbC), because they can be inherited together. HbC mutation
143-430: The gene produce several variants of the proteins which are implicated with genetic disorders such as sickle-cell disease and beta thalassemia , as well as beneficial traits such as genetic resistance to malaria . At least 50 disease-causing mutations in this gene have been discovered. HBB protein is produced by the gene HBB which is located in the multigene locus of β-globin locus on chromosome 11 , specifically on
SECTION 10
#1732776552799156-546: The major haemoglobin in adult humans. The interaction is two-fold. First, one HBB and one HBA1 combine, non-covalently, to form a dimer. Secondly, two dimers combine to form the four-chain tetramer, and this becomes the functional haemoglobin. Beta thalassemia is an inherited genetic mutation in one (Beta thalassemia minor) or both (Beta thalassemia major) of the Beta globin alleles on chromosome 11. The mutant alleles are subdivided into two groups: β0, in which no functional β-globin
169-527: The short arm position 15.4. Expression of beta globin and the neighbouring globins in the β-globin locus is controlled by single locus control region (LCR), the most important regulatory element in the locus located upstream of the globin genes. The normal allelic variant is 1600 base pairs (bp) long and contains three exons . The order of the genes in the beta-globin cluster is 5' - epsilon – gamma-G – gamma-A – delta – beta - 3'. HBB interacts with Haemoglobin, alpha 1 (HBA1) to form haemoglobin A,
#798201